Objective: To determine the prevalence, duration, and a potential cause of hum oral defect(s) in children with acute lymphoblastic leukemia (ALL) at least 1 ye ar after completion of chemotherapy. Study design: Antibo...Objective: To determine the prevalence, duration, and a potential cause of hum oral defect(s) in children with acute lymphoblastic leukemia (ALL) at least 1 ye ar after completion of chemotherapy. Study design: Antibody titers for mumps, ru beola, rubella, tetanus and diptheria toxoid, poliovirus serotypes 1, 2,and 3, H aemophilus influenzae type b, varicella, and hepatitis B were obtained from 100 children with ALL. Children with non-protective titers to these microbial antig ens were revaccinated and re-studied after anamnestic vaccine challenge. Result s: The percent of children with ALL wrotection.展开更多
文摘Objective: To determine the prevalence, duration, and a potential cause of hum oral defect(s) in children with acute lymphoblastic leukemia (ALL) at least 1 ye ar after completion of chemotherapy. Study design: Antibody titers for mumps, ru beola, rubella, tetanus and diptheria toxoid, poliovirus serotypes 1, 2,and 3, H aemophilus influenzae type b, varicella, and hepatitis B were obtained from 100 children with ALL. Children with non-protective titers to these microbial antig ens were revaccinated and re-studied after anamnestic vaccine challenge. Result s: The percent of children with ALL wrotection.
